Laregab M 300mg/500mcg Tablet is a combination medication containing Gabapentin 300mg and Methylcobalamin 500mcg, indicated for the management of neuropathic pain and peripheral neuropathies. Gabapentin, an anticonvulsant agent, modulates neuronal excitability by binding to voltage-gated calcium channels, thereby reducing the release of excitatory neurotransmitters and alleviating neuropathic pain symptoms. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. The synergistic effect of these components provides effective relief from symptoms such as burning, tingling, and numbness associated with diabetic neuropathy, postherpetic neuralgia, and other nerve-related disorders. Laregab M is generally well-tolerated; common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances. It is contraindicated in patients with known hypersensitivity to gabapentin or methylcobalamin. Dose adjustments may be necessary in renal impairment. This combination therapy should be used under medical supervision, with careful monitoring for efficacy and adverse reactions. Laregab M 300mg/500mcg Tablet offers a comprehensive approach to neuropathic pain management by combining symptomatic relief with nerve repair support.